Novel immunoassay for quantification of brain natriuretic peptide and its precursor in human blood

Clinical Chemistry

Volumn 54, Issue 9, 2008, Pages 1511-1518

  Tamm, Natalia N ^a   Seferian, Karina R ^a   Semenov, Alexander G ^b   Mukharyamova, Kadriya S ^c   Koshkina, Ekaterina V ^d   Krasnoselsky, Mihail I ^e   Postnikov, Alexander B ^a   Serebryanaya, Daria V ^a   Apple, Fred S ^f   Murakami, MaryAnn M ^f   Katrukha, Alexey G ^a  

^a HyTest Ltd   (Finland)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c Moscow Research Institute of Medical Ecology   (Russian Federation)

^d 67 City Hospital   (Russian Federation)

^e A I EVDOKIMOV MOSCOW STATE UNIVERSITY OF MEDICINE AND DENTISTRY   (Russian Federation)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 24C5; MONOCLONAL ANTIBODY AB BNP2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD SAMPLING; CONVENTIONAL BRAIN NATRIURETIC PEPTIDE IMMUNOFLUORESCENCE ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOASSAY; IMMUNODETECTION; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRECURSOR; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN STABILITY; SENSITIVITY ANALYSIS; SINGLE EPITOPE SANDWICH IMMUNOFLUORESCENCE ASSAY;

ANTIBODY SPECIFICITY; CHROMATOGRAPHY, GEL; EPITOPES; HUMANS; IMMUNOASSAY; NATRIURETIC PEPTIDE, BRAIN; PROTEIN PRECURSORS;

MUS;

EID: 51349123571     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.100545     Document Type: Article

References (16)

1. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Preliminary evaluation of the AxSYM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA Centaur BNP assay. Clin Chem 2004;50:1104-6.
2. Wu AH, Packer M, Smith A, Bijou R, Fink D, Mair J, et al. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study. Clin Chem 2004;50:867-73.
3. Ry SD, Clerico A, Giannessi D, Andreassi MG, Caprioli R, Iascone MR, et al. Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an immunoradiometric assay method. Scand J Clin Lab Invest 2000;60:81-90.
4. Fischer Y, Filzmaier K, Stiegler H, Graf J, Fuhs S, Franke A, et al. Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide. Clin Chem 2001;47:591-4.
5. Apple FS, Panteghini M, Ravkilde J, Mair J, Wu AH, Tate J, et al. Quality specifications for B-type natriuretic peptide assays. Clin Chem 2005;51:486-93.
6. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256:495-7.
7. Katrukha AG, Bereznikova AV, Esakova TV, Pettersson K, Lovgren T, Severina ME, et al. Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. Clin Chem 1997;43:1379-85.
8. Seferian KR, Tamm NN, Semenov AG, Mukharyamova KS, Tolstaya AA, Koshkina EV, et al. The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure. Clin Chem 2007;53:866-73.
9. Belenky A, Smith A, Zhang B, Lin S, Despres N, Wu AH, Bluestein BI. The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma. Clin Chim Acta 2004;340:163-72.
10. Shimizu H, Aono K, Masuta K, Asada H, Misaki A, Teraoka H. Degradation of human brain natriuretic peptide (BNP) by contact activation of blood coagulation system. Clin Chim Acta 2001;305:181-6.
11. Murdoch DR, Byrne J, Morton JJ, McDonagh TA, Robb SD, Clements S, et al. Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice. Heart 1997;78:594-7.
12. Buckley MG, Marcus NJ, Yacoub MH, Singer DR. Prolonged stability of brain natriuretic peptide: importance for non-invasive assessment of cardiac function in clinical practice. Clin Sci (Lond) 1998;95:235-9.
13. Evans MJ, Livesey JH, Ellis MJ, Yandle TG. Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. Clin Biochem 2001;34:107-12.
14. Murdoch DR, Byrne J, Farmer R, Morton JJ. Disparity between studies of the stability of BNP in blood: comparison of endogenous and exogenous peptide. Heart 1999;81:212-3.
15. Liang F, O'Rear J, Schellenberger U, Tai L, Lasecki M, Schreiner GF, et al. Evidence for functional heterogeneity of circulating B-type natriuretic peptide. J Am Coll Cardiol 2007;49:1071-8.
16. Katrukha AG, Tamm NN, Semenov AG, Seferian KR, Postnikov AB, Agafonov M, et al. Recombinant proform of brain natriuretic peptide (proBNP), expressed in eukaryotic cells as a stable standard for BNP immunoassay. Clin Chem 2007;53(Suppl):A23.